Patient Rating:

4.6 out of 5

44 Patient Ratings
6 Patient Comments

Daniel Webster Fults, III, M.D.

Patient Rating:

4.6 out of 5

44 Patient Ratings
6 Patient Comments



  • English
  • German
  • Spanish

Clinical Details

Phone Number Clinical Office Address
(801) 585-6065
Clinical Neurosciences Center
175 North Medical Drive East
Salt Lake City, UT 84132


Daniel W. Fults III, MD is Professor of Neurosurgery at the University of Utah and is a member of Huntsman Cancer Institute’s Brain Tumor Program. As a physician-researcher, Dr. Fults’s clinical practice is centered on brain tumor treatment. Malignant brain tumors found in children is the primary focus of his laboratory research.

Board Certification and Academic Information

Academic Departments Neurosurgery - Professor
Oncological Sciences - Adjunct Professor
Academic Divisions Adult Neurosurgery
Board Certification American Board of Neurological Surgery (Neurosurg)
Cancer Center Programs Cell Response & Regulation

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
My confidence in care provider
Time care provider spent with me
Care provider spoke using clear language
Care provider's effort to include me in decisions
Care provider's concern for questions & worries
Care provider's explanation of condition/problem
Wait time at clinic
Care provider's friendliness and courtesy

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

October 06, 2015

excellent overLL experience -- Dr. Fults was outstanding.

June 17, 2013

every thing went really well. I this is very different situation because it was brain issue more than any thing

March 08, 2013

I have been under Dr. Fults care for about 20 years and find him most competent, friendly and informative. His assistant, Melody Fairborne, is also highly rated in my opinion.

March 01, 2013

Overall, excellent. However it wasn't clear that the physician had looked at the details of the path report before entering the room. This produced a brief period of confusion about the nature of the problem and what needed to be done.

January 16, 2013

The neurosurgeon answered all questions, thoroughly explained risks and benefits of surgery. He was unhurried, thoughtful, fully present and engaged and revealed a temperament that gave us great confidence in his competence.

October 29, 2012

We traveled here from Wyoming. When we put out an email to friends and family, 4 people said go to Huntsman because of their experience. We listened and we are glad we did. We will recommend Huntsmen to anyone in need.

Academic Profile

Research Interests

  • Medulloblastoma
  • Childhood Cancer
  • Molecular Biology
  • Surgery for Brain Tumors

Board Certification and Academic Information

Academic Departments Neurosurgery - Professor
Oncological Sciences - Adjunct Professor
Academic Divisions Adult Neurosurgery
Board Certification American Board of Neurological Surgery (Neurosurg)
Cancer Center Programs Cell Response & Regulation

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-6908 Clinical Neurosciences Center
Department of Neurosurgery
175 North Medical Drive East
Salt Lake City, UT 84132
Huntsman Cancer Institute
2000 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

Dr. Fults is Professor of Neurosurgery and Oncological Sciences at the University of Utah and holder of the M. Peter and Robyn Heilbrun endowed chair in neurosurgery. His is a board-certified neurosurgeon and a member of the brain tumor program at the Huntsman Cancer Institute. He is also an HCI investigator and member of the Cell Response and Regulation program. Dr. Fults is a clinician-scientist who has a long-standing commitment to the idea that advances in brain tumor treatment depend critically on understanding the molecular biology of this devastating disease. He has been the principal investigator of an NIH-funded research program in brain tumor biology for over 28 years.

Research in Dr. Fults’s laboratory is now focused on medulloblastoma, a malignant brain tumor that arises in the cerebellum in children. Aggressive treatments, combining surgery with radiation and chemotherapy, now offer children a 70% chance of being cured, but these harsh treatments carry a high risk of causing disabling neurological side effects, including neuropsychiatric challenges, stunted body growth, and hormonal imbalance, later in life. Hope for extending disease-free survival and eliminating treatment-related neurotoxicity rests on developing new treatments that specifically target the signaling molecules that drive medulloblastoma growth.

Dr. Fults studies how signaling molecules that normally govern the growth and differentiation of normal stem cells in the brain cause medulloblastoma. His experimental approach uses genetically engineered mice, in which genes can be transferred and expressed in stem cells in the brain. His research team discovered that activation of the Hedgehog signaling pathway, which is important in normal brain development, induces tumors in mice that closely resemble human medulloblastomas. In Dr. Fults’s lab, this mouse model is also used for preclinical testing of new therapies and for discovering the genes that cause medulloblastomas to metastasize to the spine, a condition that carries a grim prognosis for patients.


Education History

Type School Degree
Fellowship University of North Carolina
Molecular Biology
Residency Wake Forest University School of Medicine
Internship North Carolina Baptist Hospital
Professional Medical University of Texas Southwestern Medical School
Undergraduate University of Texas


Selected Provider Publications

Journal Article

  1. Jenkins NC, Rao G, Eberhart CG, Pedone CA, Dubuc AM, Fults DW (2016). Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice. J Neurooncol, 126(3), 415-24.
  2. Morrissy AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, Remke M, Cavalli FM, Ramaswamy V, Lindsay PE, Jelveh S, Donovan LK, Wang X, Luu B, Zayne K, Li Y, Mayoh C, Thiessen N, Mercier E, Mungall KL, Ma Y, Tse K, Zeng T, Shumansky K, Roth AJ, Shah S, Farooq H, Kijima N, Holgado BL, Lee JJ, Matan-Lithwick S, Liu J, Mack SC, Manno A, Michealraj KA, Nor C, Peacock J, Qin L, Reimand J, Rolider A, Thompson YY, Wu X, Pugh T, Ally A, Bilenky M, Butterfield YS, Carlsen R, Cheng Y, Chuah E, Corbett RD, Dhalla N, He A, Lee D, Li HI, Long W, Mayo M, Plettner P, Qian JQ, Schein JE, Tam A, Wong T, Birol I, Zhao Y, Faria CC, Pimentel J, Nunes S, Shalaby T, Grotzer M, Pollack IF, Hamilton RL, Li XN, Bendel AE, Fults DW, Walter AW, Kumabe T, Tominaga T, Collins VP, Cho YJ, Hoffman C, Lyden D, Wisoff JH, Garvin JH Jr, Stearns DS, Massimi L, Schuller U, Sterba J, Zitterbart K, Puget S, Ayrault O, Dunn SE, Tirapelli DP, Carlotti CG, Wheeler H, Hallahan AR, Ingram W, MacDonald TJ, Olson JJ, Van Meir EG, Lee JY, Wang KC, Kim SK, Cho BK, Pietsch T, Fleischhack G, Tippelt S, Ra YS, Bailey S, Lindsey JC, Clifford SC, Eberhart CG, Cooper MK, Packer RJ, Massimino M, Garre ML, Bartels U, Tabori U, Hawkins CE, Dirks P, Bouffet E, Rutka JT, Wechsler-Reya RJ, Weiss WA, Collier LS, Dupuy AJ, Korshunov A, Jones DT, Kool M, Northcott PA, Pfister SM, Largaespada DA, Mungall AJ, Moore RA, Jabado N, Bader GD, Jones SJ, Malkin D, Marra MA, Taylor MD (2016). Divergent clonal selection dominates medulloblastoma at recurrence. Nature, 529(7586), 351-7.
  3. Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM (2015). Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell, 27(5), 728-743.
  4. Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L, Ra YS, Ho KC, Chan TS, Sin-Chan P, Dunham CP, Yip S, Ng HK, Lu JQ, Albrecht S, Pimentel J, Chan JA, Somers GR, Zielenska M, Faria CC, Roque L, Baskin B, Birks D, Foreman N, Strother D, Klekner A, Garami M, Hauser P, Hortobgyi T, Bognr L, Wilson B, Hukin J, Carret AS, Van Meter TE, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheineman K, Johnston D, Michaud J, Zelcer S, Hammond R, Ramsay DA, Fleming AJ, Lulla RR, Fangusaro JR, Sirachainan N, Larbcharoensub N, Hongeng S, Barakzai MA, Montpetit A, Stephens D, Grundy RG, Schller U, Nicolaides T, Tihan T, Phillips J, Taylor MD, Rutka JT, Dirks P, Bader GD, Warmuth-Metz M, Rutkowski S, Pietsch T, Judkins AR, Jabado N, Bouffet E, Huang A (2015). Molecular subgroups of atypical teratoid rhabdoid tumors in children: an integrated genomic and clinicopathologic analysis. Lancet Oncol, 16(5), 569-582.
  5. Jenkins NC, Kalra RR, Dubuc A, Sivakumar W, Pedone CA, Wu X, Taylor MD, Fults DW (2014). Genetic drivers of metastatic dissemination in sonic hedgehog medulloblastoma. Acta Neuropathol Commun, 2(1), 85.
  6. Mack SC, Witt H, Piro RM, Gu L, Zuyderduyn S, Stutz AM, Wang X, Gallo M, Garzia L, Zayne K, Zhang X, Ramaswamy V, Jager N, Jones DT, Sill M, Pugh TJ, Ryzhova M, Wani KM, Shih DJ, Head R, Remke M, Bailey SD, Zichner T, Faria CC, Barszczyk M, Stark S, Seker-Cin H, Hutter S, Johann P, Bender S, Hovestadt V, Tzaridis T, Dubuc AM, Northcott PA, Peacock J, Bertrand KC, Agnihotri S, Cavalli FM, Clarke I, Nethery-Brokx K, Creasy CL, Verma SK, Koster J, Wu X, Yao Y, Milde T, Sin-Chan P, Zuccaro J, Lau L, Pereira S, Castelo-Branco P, Hirst M, Marra MA, Roberts SS, Fults D, Massimi L, Cho YJ, Van Meter T, Grajkowska W, Lach B, Kulozik AE, von Deimling A, Witt O, Scherer SW, Fan X, Muraszko KM, Kool M, Pomeroy SL, Gupta N, Phillips J, Huang A, Tabori U, Hawkins C, Malkin D, Kongkham PN, Weiss WA, Jabado N, Rutka JT, Bouffet E, Korbel JO, Lupien M, Aldape KD, Bader GD, Eils R, Lichter P, Dirks PB, Pfister SM, Korshunov A, Taylor MD (2014). Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature, 506(7489), 445-50.
  7. Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, Luu B, Jones DT, Garzia L, Dubuc AM, Zhukova N, Vanner R, Kros JM, French PJ, Van Meir EG, Vibhakar R, Zitterbart K, Chan JA, Bognar L, Klekner A, Lach B, Jung S, Saad AG, Liau LM, Albrecht S, Zollo M, Cooper MK, Thompson RC, Delattre OO, Bourdeaut F, Doz FF, Garami M, Hauser P, Carlotti CG, Van Meter TE, Massimi L, Fults D, Pomeroy SL, Kumabe T, Ra YS, Leonard JR, Elbabaa SK, Mora J, Rubin JB, Cho YJ, McLendon RE, Bigner DD, Eberhart CG, Fouladi M, Wechsler-Reya RJ, Faria CC, Croul SE, Huang A, Bouffet E, Hawkins CE, Dirks PB, Weiss WA, Schuller U, Pollack IF, Rutkowski S, Meyronet D, Jouvet A, Fevre-Montange M, Jabado N, Perek-Polnik M, Grajkowska WA, Kim SK, Rutka JT, Malkin D, Tabori U, Pfister SM, Korshunov A, von Deimling A, Taylor MD (2013). TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol, 126(6), 917-29.

Book Chapter

  1. Fults DW (2012). Medulloblastoma Initiation and Growth: Role of Hepatocyte Growth Factor. In MA Hayat (Ed.), Pediatric Cancer: Diagnosis, Therapy, and Prognosis (3, pp. 93-101). Springer.

Global Impact

Global Impact


Description Country
Somatic Cell Gene Transfer to Model Medulloblastoma in Mice, Arthur and Sonia Labatt Brain Tumor Research Center, University of Toronto–Toronto, Canada; December 11, 2008. Canada
Somatic Cell Gene Transfer to Navigate Signaling Pathways in a Mouse Model of Medulloblastoma, 9th International Conference on Drug and Gene-Based Therapeutics–Agia Pelagia, Crete, September 5, 2006. Greece
Genetically Engineered Mouse Models for Pediatric Cancer, 2nd International Conference on New Drugs in Pediatric Oncology – Bologna, Italy; January 21, 2008. Italy

Clinical Trials

Video & News